TRex Bio, Inc. ($TRXB)
Filing Information
| Accession Number | 0001829126-26-011084 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 13, 2026 |
| Document | View SEC Filing |
Transactions
12
Total Shares
5,672,043
Total Value
$1,299,998.00
P&L
-0.2% ($2,785.71)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
10% Owner | Common Stock | โ | Oct 8, 2026 | Purchase | 89,783 | $14.00 | $1,256,962.00 | 214,869 | Indirect | By SV Life Sciences Fund VI, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 13, 2026 | Conversion | 1,574,074 | $0.00 | $0.00 | 1,788,943 | Indirect | By SV Life Sciences Fund VI, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 13, 2026 | Conversion | 475,411 | $0.00 | $0.00 | 2,264,354 | Indirect | By SV Life Sciences Fund VI, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 8, 2026 | Purchase | 3,074 | $14.00 | $43,036.00 | 7,356 | Indirect | By SV Life Sciences Fund VI Strategic Partners, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 13, 2026 | Conversion | 53,892 | $0.00 | $0.00 | 61,248 | Indirect | By SV Life Sciences Fund VI Strategic Partners, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 13, 2026 | Conversion | 16,277 | $0.00 | $0.00 | 77,525 | Indirect | By SV Life Sciences Fund VI Strategic Partners, L.P. | View Details | |
10% Owner | Common Stock | โ | Oct 13, 2026 | Conversion | 669,939 | $0.00 | $0.00 | 669,939 | Indirect | By SV Trex Coinvestment, L.P. | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 1,574,074 | $0.00 | $0.00 | 0 | Indirect | By SV Life Sciences Fund VI, L.P. | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 475,411 | $0.00 | $0.00 | 0 | Indirect | By SV Life Sciences Fund VI, L.P. | View Details | |
10% Owner | Series A Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 53,892 | $0.00 | $0.00 | 0 | Indirect | By SV Life Sciences Fund VI Strategic Partners, L.P. | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 16,277 | $0.00 | $0.00 | 0 | Indirect | By SV Life Sciences Fund VI Strategic Partners, L.P. | View Details | |
10% Owner | Series B Preferred Stock | Derivative | Oct 13, 2026 | Conversion | 669,939 | $0.00 | $0.00 | 0 | Indirect | By SV Trex Coinvestment, L.P. | View Details |